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Influenza viruses cause epidemics and pandemics. Like all viruses, influenza viruses rely on the host cellular
machinery to support their life cycle. Accordingly, identification of the host functions co-opted for viral repli-
cation is of interest to understand the mechanisms of the virus life cycle and to find new targets for the devel-
opment of antiviral compounds. Among the various approaches used to explore host factor involvement in
the influenza virus replication cycle, perhaps the most powerful is RNAi-based genome-wide screening,
which has shed new light on the search for host factors involved in virus replication. In this review, we
examine the cellular genes identified to date as important for influenza virus replication in genome-wide
screens, assess pathways that were repeatedly identified in these studies, and discuss how these pathways
might be involved in the individual steps of influenza virus replication, ultimately leading to a comprehensive
understanding of the virus life cycle.Introduction
Viruses, which consist of nucleic acid encased in a protein shell,
are parasites of their host organisms. Despite their simple struc-
tures, viruses employ sophisticated mechanisms to replicate
within their hosts. A ‘‘host cellular factory’’ has thousands of
machines, which viruses co-opt or subvert for each step of their
life cycle. Viruses generally initiate their life cycle by attaching to
host cell surface receptors, entering the cells, uncoating the viral
nucleic acid, and replicating their genome. After new copies of
viral proteins and genes are synthesized, these components
assemble into progeny virions, which exit the cell. For each
step, viruses need to use many host cellular functions, and iden-
tifying these host functions has long been of great interest in
virology to further our understanding of the precise mechanisms
of the viral life cycle.
Influenza viruses cause annual epidemics and recurring
pandemics with potentially severe consequences for public
health and the global economy. The first influenza pandemic of
the 21st century was caused by the 2009 H1N1 virus and has
so far resulted in 42–86 million cases of infection worldwide
(http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm). Inaddi-
tion, highly pathogenic avian H5N1 influenza A viruses have
spread throughout Asia, Europe, and Africa, overcoming host
species barriers to infect humans, with fatal outcome in many
cases (Webster and Govorkova, 2006; Yen and Webster, 2009).
Antiviral drugs, such as oseltamivir, zanamivir (Hayden, 2001),
and amantadine/rimantadine (Davies et al., 1964), are available
for prophylaxis and treatment of influenza virus infection;
however, most human H3N2 and H1N1, including pandemic
2009 H1N1, influenza viruses are resistant to amantadine/riman-
tadine (Bright et al., 2005, 2006; Dawood et al., 2009). Moreover,
the frequency with which H1N1 influenza viruses are becomingoseltamivir resistant is a cause for concern and highlights the
urgent need for new antiviral drugs (Nicoll et al., 2008) (http://
www.who.int/csr/disease/influenza/h1n1_table/en/index.html).
Influenza A viruses are enveloped negative-strand RNA
viruses with eight RNA segments encoding at least 10 viral
proteins (reviewed in Palese, 2007). Two additional viral proteins,
PB1-F2 and PB1 N40, have been identified, although not all
strains encode these proteins (Chen et al., 2001; Wise et al.,
2009). The virus particles are enclosed by a lipid envelope, which
is derived from the host cellular membrane. Three viral proteins,
the surface glycoproteins hemagglutinin (HA) and neuraminidase
(NA) and the M2 ion channel protein, are embedded in the lipid
bilayer of the viral envelope. The HA protein binds to sialic
acid-containing receptors on the host cell surface and mediates
fusion of the viral envelope with the endosomal membrane
after receptor-mediated endocytosis (Palese, 2007; Skehel and
Wiley, 2000). By contrast, the NA protein plays a crucial role
late in infection by removing sialic acid from sialyloligosacchar-
ides, thereby releasing newly assembled virions from the cell
surface and preventing the self-aggregation of virus particles.
Underneath the lipid bilayer lies the matrix protein (M1), a major
structural protein. Within the virus shell are eight viral ribonucleo-
protein (vRNP) complexes, each composed of viral RNA (vRNA)
associated with the nucleoprotein NP and the three components
of the viral RNA polymerase complex (PB2, PB1, and PA). The
NS1 protein, which counteracts the cellular interferon response,
is synthesized from an unspliced mRNA, and a spliced mRNA
yields the NS2, or NEP, protein, which mediates nuclear export
of vRNP complexes. In addition, the recently identified PB1-F2
protein, which is encoded by the PB1 segment, is thought to
play a role in viral pathogenicity (Chen et al., 2001; Conenello
et al., 2007; McAuley et al., 2007; Zamarin et al., 2006).Cell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc. 427
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extensively during the last decade, relatively little is known about
the cellular factors involved in influenza virus life cycle. Here, we
review recent genome-wide screens that aim to close this critical
gap in influenza virus research.
Dawn of a New Era: The Application of Genome-wide
Screens to Identify Host Factors Involved in Influenza
Virus Replication
A number of interactions between viral components and specific
host cell gene products have now been identified. Although most
host molecules remain elusive, emerging data indicate that their
identification and characterization will provide new insights into
the mechanisms by which viruses complete their life cycle.
Moreover, such knowledge would illuminate potentially useful
targets for therapeutic intervention. Indeed, antiviral drugs tar-
geting host cell factors involved in viral replication have been
tested for the treatment of human immunodeficiency virus type
I (HIV-1) with promising results (Coley et al., 2009). However,
this goal would generally take several decades to achieve with
conventional genetic screening methods and mammalian cell
cultures.
Genome-wide RNAi Screens
Many laboratories have expended great effort in the search
for new host factors involved in the virus replication cycle by
using various strategies. A powerful approach is systematic,
genome-wide RNA interference (RNAi) analysis. RNAi is a
regulatory mechanism that uses double-stranded RNA (dsRNA)
molecules to direct homology-dependent suppression of gene
activity (reviewed in Mello and Conte, 2004). This powerful
cellular process has been extensively applied for studies of
gene functions and therapeutic approaches for disease treat-
ment. Now, this technology offers a new exciting tool for the
exploration of novel host genes involved in virus replication
(Brass et al., 2008, 2009; Cherry et al., 2005; Goff, 2008; Hao
et al., 2008; Ko¨nig et al., 2008, 2010; Krishnan et al., 2008; Li
et al., 2009; Zhou et al., 2008).
The first genome-wide screen for the identification of host
factors involved in influenza virus replication was reported by
Hao et al. (2008) (Table 1). Because RNAi-based screening
was not well established in mammalian cells at that time, the
authors used Drosophila RNAi technology. Studies in Drosophila
have made numerous fundamental contributions to our under-
standing of mammalian cell biology because of the high degree
of genetic conservation between Drosophila and vertebrates.
Hao et al. (2008) first established an influenza virus infection
system in Drosophila cells by modifying the influenza virus
genetically to infect Drosophila cells and express a reporter
gene product in infected cells. This system supported influenza
virus replication from post-entry to the protein expression step
in the life cycle (Table 1). The authors tested an RNAi library
against 13,071 genes (90% of the Drosophila genome) and iden-
tified 110 genes whose depletion in Drosophila cells significantly
affected reporter gene expression from the influenza virus-like
RNA (see Table S3 available online for the list of genes). Of those
110 candidates, they validated roles for the host proteins
ATP6V0D1 (an ATPase), COX6A1 (a cytochrome c oxidase
subunit), and NXF1 (a nuclear RNA export factor) in the replica-
tion of H5N1 and H1N1 influenza A viruses in mammalian cells.428 Cell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc.These studies showed the feasibility and power of genome-
wide RNAi screens to identify previously unrecognized host
proteins required for influenza virus replication.
The development of mammalian RNAi-based screening now
enables the comprehensive analysis of mammalian host cell
functions in influenza virus replication. Recently, Brass et al.
(2009), Ko¨nig et al. (2010), and Karlas et al. (2010) reported
genome-wide RNAi screens in mammalian cells that identified
host proteins important for influenza virus replication (Table 1).
They tested siRNAs targeting more than 17,000 human genes
in human osteosarcoma (Brass et al., 2009) and the human
lung cell line A549 (Karlas et al., 2010; Ko¨nig et al., 2010), respec-
tively. Because the readout of the assay was the measurement of
a viral protein or a reporter protein encoded by the viral genome,
the systems used by Brass et al. (2009) and Ko¨nig et al. (2010)
allowed the identification of host gene products important for
the early to mid stages of the influenza virus life cycle, including
virus entry, uncoating, vRNP nuclear import, genome transcrip-
tion, and viral protein translation. These systems identified 133
(Brass et al., 2009) and 295 (Ko¨nig et al., 2010) human genes
whose depletion affected the efficiency of HA cell surface
expression or reporter gene expression, respectively (Table 1;
see Table S3 for the list of genes). In contrast, Karlas et al.
(2010) studied the entire viral replication cycle, from viral entry
to budding, by determining virus infectivity titers in culture super-
natants from siRNA-treated, virus-infected A549 cells. This
approach identified 287 human genes important for influenza
virus replication (Karlas et al., 2010) (see Table S3 for the list of
genes).
Shapira et al. (2009) employed a different tactic. They
combined the results of yeast two-hybrid analyses, genome-
wide transcriptional gene expression profiling, and an RNAi
screen (Shapira et al., 2009). First, they built a physical interac-
tion map for viral proteins and human cellular molecules by
applying computational analysis to their comprehensive yeast
two-hybrid assay. This physical map indicated that the viral
proteins of influenza interacted with ‘‘a significantly greater
number of human proteins than expected from the human inter-
action network, even when compared to other viruses’’ (Shapira
et al., 2009), suggesting that influenza viruses have to maximize
the diversity of functions for each protein (Shapira et al., 2009).
They then examined which cellular gene products were differen-
tially expressed in primary human bronchial epithelial cells
exposed to influenza virus or viral RNA. Collectively, these
approaches identified 1745 potential host factors with roles in
the influenza virus life cycle (Shapira et al., 2009). Further valida-
tion using siRNAs targeting to 1745 genes narrowed this list
to 616 human genes whose products affected influenza virus
replication.
Other Approaches
Proteomics approaches and yeast two-hybrid analyses have
also been used to identify host molecules that interact with influ-
enza virus components (reviewed in Nagata et al., 2008). Several
host factors involved in the steps of viral genome replication and
transcription have been identified (Deng et al., 2006; Engelhardt
et al., 2005; Huarte et al., 2001; Jorba et al., 2008; Kawaguchi
and Nagata, 2007; Momose et al., 2001, 2002; Resa-Infante
et al., 2008), as well as NS1 protein-interacting host factors asso-
ciated with immune responses (reviewed in Hale et al., 2008).
Table 1. Summary of Genome-wide Screens for the Identification of Host Factors Involved in Influenza Virus Replication
Reference
Methods
(Approach)
Cells Used for
RNAi Screen Virus Strain Detection Methods
Steps in the Viral
Life Cycle Covered
by the Screen
Number of Hits/
Number of
Genes Tested
Brass et al.
(2009)
RNAi screen Osteosarcoma
cells (U2OS)
A/Puerto Rico/8/34
(PR8; H1N1)
HA expression
on cell surface
entry, uncoating,
nuclear import,
transcription,
translation, HA
trafficking to
cell surface
133/17,877
Hao et al.
(2008)
RNAi screen Drosophila
cells
Recombinant
A/WSN/33 (WSN;
H1N1) virus
possessing vesicular
stomatitis virus
glycoprotein G and
NA-Luciferase (Luc)
genes
luciferase activity uncoating, nuclear
import, transcription,
translation
110/13,071
Ko¨nig et al.
(2010)
RNAi screen human lung
cells (A549)
recombinant WSN
possessing HA-Luc
reporter gene
luciferase activity entry, uncoating,
nuclear import,
transcription,
translation
295/19,628
Karlas et al.
(2010)
RNAi screen human lung
cells (A549)
WSN (H1N1);
H1N1 2009
virus yield
determined by
NP staining and
luciferase activity
entry, uncoating,
nuclear import,
transcription,
translation, nuclear
export, protein
transportation/
processing,
assembly, budding
287/22,843
Shapira et al.
(2009)
Y2H; microarray;
RNAi screen
HBEC PR8 (H1N1);
A/Udorn/307/72
(H3N2)
virus yield
determined by
luciferase activity
entry, uncoating,
nuclear import,
transcription,
translation, nuclear
export, protein
transportation/
processing
assembly, budding
616/1,745
(RNAi screen)
Sui et al.
(2009)
RHGP MDCK cells Udorn (H3N2) cloning of cells
resistant to influenza
virus infection
entry, uncoating,
nuclear import,
transcription,
translation, nuclear
export, protein
transportation/
processing
assembly, budding
110 clones,
sequenced
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41 host cellular molecules that interact with influenza vRNPs,
including nucleoplasmin, which may play a role in viral RNA
synthesis.
A library encompassing about 4800 yeast single-gene deletion
strains, which covers 80% of all yeast genes, has been used to
explore host gene involvement in virus replication, especially
that of several positive-strand RNA viruses (Kushner et al.,
2003; Panavas et al., 2005). Naito et al. (2007) developed
a system for influenza virus genome replication and transcription
in Saccharomyces cerevisiae and conducted a screen with a
sublibrary of 354 deletion strains, each of which lacked a gene
encoding a putative nucleic acid-binding/-related functionalprotein. This approach resulted in the identification of several
host factors that affected influenza RNA synthesis (Naito et al.,
2007).
Sui et al. (2009) employed a new technique called ‘‘random
homozygous gene perturbation’’ (RHGP) to identify host factors
involved in influenza virus replication. This system uses a lentivi-
ral-based genetic element containing a promoter (e.g., the
cytomegalovirus immediate early promoter). The genetic
element is designed to integrate at a single site in one allele of
the genome in either the sense or antisense orientation. Integra-
tion of this element in the antisense orientation disrupts gene
expression in one allele. Moreover, because this element con-
tains a promoter, antisense RNA is expressed and can abrogateCell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc. 429
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integrated in the sense orientation in one allele, either overex-
pression of the gene or expression of a dominant-negative
form occurs, leading to an altered phenotype. Unlike RNAi
screens, the RHGP system can theoretically knock down or
overexpress any gene without any prior knowledge or annotation
of that gene, resulting in alteration of the phenotype. Sui et al.
(2009) generated an RHGP library in mammalian cells, followed
by infection with a dose of influenza virus that results in cell
death. They then isolated the influenza virus-resistant cell clones
and identified 110 human genes that contributed to the host cell
resistance to viral infection, demonstrating the usefulness of this
RGHP system for genome-wide screening.
Pair-Wise Comparison among Six Independent
Genome-wide Screens for Human Genes Involved
in Influenza Virus Replication
In the six independent genome-wide screens described above
(Brass et al., 2009; Hao et al., 2008; Karlas et al., 2010; Ko¨nig
et al., 2010; Shapira et al., 2009; Sui et al., 2009), a total of
1449 human genes were identified as potential host factors
involved in influenza virus replication (including 110 Drosophila
genes that have human orthologs; Tables S1A and S1B), indi-
cating that about 5.8% of human protein-coding genes may
contribute to the life cycle of influenza virus. However, there is
the possibility that these high-throughput screens contain false
positives. To narrow down the genes important for influenza viral
replication, we analyzed the candidate genes identified in these
screens by pair-wise comparison and found 128 human genes
that affected influenza virus replication in at least two screens
(Table S2). The number of genes common between pairs of
screens is relatively small (from 0 to 32 genes in the 15 pair-
wise comparisons). This low incidence of overlap has also
been observed in three RNAi screens designed to identify host
factors for HIV-1 replication (Brass et al., 2008; Ko¨nig et al.,
2008; Zhou et al., 2008), and it could be due to differences in
screening systems (e.g., RNAi screen versus RHGP library
screen) or other conditions such as cell type, virus strains, and/
or detection methods. Indeed, the number of common genes
was highest in the comparison between the Ko¨nig and Karlas
screens (32 human genes) (Table S2), presumably because
both screens were based on RNAi and used the same human
lung cells. In addition, the analysis of raw data, particularly the
‘‘cut-off’’ used to determine candidates, likely differed among
the studies. Nonetheless, a number of factors were identified in
several screens (see below for more details), suggesting their
importance in the influenza virus life cycle.
Network Analysis of Influenza-Host Protein Interactions
For the set of 128 human genes that were identified in two or
more screens and are likely involved in influenza virus replication,
we next determined major gene categories. Our analysis with
the PANTHER Classification System (Mi et al., 2005) revealed
several enriched gene categories associated with molecular
functions, such as nucleic acid-binding proteins, kinases, tran-
scription factors, ribosomal proteins, hydrogen transporters,
and proteins involved in mRNA splicing. Moreover, we found
enrichment for cellular proteins involved in biological processes
such as protein metabolism and modification, signal transduc-430 Cell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc.tion, protein phosphorylation, nucleoside, nucleotide and nucleic
acid metabolism, and transport. Analysis by Reactome, which is
a curated knowledgebase of biological pathways (Matthews
et al., 2009), revealed several other overrepresented events,
including eukaryotic translation initiation, regulation of gene
expression, processing of capped intron-containing pre-mRNAs,
and Golgi-to-ER retrograde transport. Further, we analyzed inter-
actions of the set of these 128 genes by using GeneGo (GeneGo
Inc, MI, USA) (Table S4A). We then integrated this data set with
information on the viral and cellular interaction partners of viral
proteins as reported by Ko¨nig et al. (2010) and Shapira et al.
(2009) (Table S4B), resulting in a network of host-influenza virus
interactions (Figures 1–3). In addition, this network included
several subnetworks associated with specific biological pro-
cesses, such as translation initiation, processing of pre-mRNA,
and proton-transporting ATPase functions.
Insights into Host Factors Involved in the Influenza Virus
Life Cycle
Based on the analyses described above, influenza virus-host
interactions can be mapped to individual steps of the influenza
virus life cycle (Figure 4), as outlined below.
Endocytosis, Fusion, and Uncoating
Once virus particles attach to a cell surface receptor, they are
mainly internalized by clathrin-dependent endocytosis, although
influenza virus also uses a nonclathrin-dependent endocytic
pathway (Marsh and Helenius, 2006; Matlin et al., 1981; Rust
et al., 2004; Sieczkarski and Whittaker, 2002). The importance
of both early and late endosomes in influenza virus entry has
been demonstrated with dominant-negative forms of the
GTPases Rab5 and Rab7/protein kinase C b II (PKCbII), which
regulate the functions of early and late endosomes, respectively
(Sieczkarski et al., 2003; Sieczkarski and Whittaker, 2003).
Rab10 (RAB10), which controls the movement of endosomes
(Glodowski et al., 2007), was identified in two screens (Table S3).
Moreover, four of the seven subunits of the coatomer 1 (COPI)
vesicular transport complex (i.e., ARCN1, COPA, COPB2, and
COPG), which is required for the formation of intermediate trans-
port vesicles between the early and late endosomes and for
retrograde Golgi-to-ER transport (Aniento et al., 1996; Cai
et al., 2007; Whitney et al., 1995), were identified in five indepen-
dent screens (Table S3), indicating the biological significance
of this host cell machinery in the early steps of the influenza virus
life cycle.
Uncoating of viral particles occurs upon fusion between the
viral and endosomal membranes, is mediated by HA, and leads
to the release of vRNPs into the cytoplasm (Stegmann et al.,
1990). The M2 ion channel protein functions in the endosomes
to lower the pH of virion interior, resulting in the disassociation
of the viral matrix M1 protein from the vRNP complex, which
can then be imported to the nucleus (Helenius, 1992). Proton-
transporting V-type ATPase functions in both the acidification
and fusion of the cellular compartments (Stevens and Forgac,
1997). Four of the six screens identified at least two subunits
of this V-type ATPase complex as host factors required for
influenza virus infection (Table S3). Although this complex was
thought to be generally involved in the low pH-dependent
membrane fusion between endosomes and virions, knockdown
of ATP6V0D1 caused significant inhibition of influenza virus
Figure 1. A Network of Host-Influenza Virus Interactions: Host and Viral Proteins
Using GeneGo (GeneGo Inc, MI, USA), we analyzed the interactions of the 128 human genes identified to be involved in influenza virus replication in at least two
genome-wide screens (Table S4A). We then integrated this information with data on host protein-virus interactions and interactions among viral proteins, as
reported by Ko¨nig et al. (2010) and Shapira et al. (2009) (Table S4B). An interaction network between host and viral proteins (i.e., PA, PB1, PB2, NP, HA, NA,
M1, M2, NS1, NEP/NS2, and PB1-F2) was visualized by using Cytoscape (http://cytoscape.org/). Yellow and lilac nodes indicate influenza viral components
and host proteins, respectively. Red circles indicate clusters associated with particular biological processes in the interaction networks, as identified by MCODE
(‘‘Molecular Complex Detection’’) analysis (Bader and Hogue, 2003): (1) translation initiation, (2) pre-mRNA processing, and (3) proton-transporting V-type ATPase.
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pH for fusion (Hao et al., 2008). This finding implies a specific
role for the complex in influenza virus replication.Transport of vRNP into the Host Nucleus
Replication/transcription of influenza virus genomic RNA occurs
in the nucleus (reviewed in Engelhardt and Fodor, 2006; Palese,Cell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc. 431
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Figure 2. A Network of Host-Influenza Virus Interactions: Host and vRNP
An interaction network between host and vRNP was analyzed and visualized in the same way described in Figure 1. Yellow and lilac nodes indicate vRNP of
influenza virions and host proteins, respectively. Red circles indicate clusters associated with particular biological processes in the interaction networks, as iden-
tified by MCODE analysis (Bader and Hogue, 2003): (1) translation initiation, (2) pre-mRNA processing, and (3) proton-transporting V-type ATPase.
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incoming virus particles must be transported into the nucleus
through the nuclear pores. The nuclear import of RNP complexes
is dependent on the active import machinery of the host cell
nuclear pore complex (NPC) because of the size of these
complexes (10–15 nm wide and 30–120 nm long). In a classic
nuclear import pathway, importin a recognizes a cargo protein
containing nuclear localization signals (NLS) and binds to impor-432 Cell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc.tin b, and the cargo/importin a/b complex is transported into the
nucleus through the NPC. For influenza virus, RanBP5 (or im-
portin 5), importin a1/a2, and importin a1/importin a5 have
been shown to bind to PB1-PA dimers (Deng et al., 2006), NP
(O’Neill et al., 1995; Wang et al., 1997), and PB2 (Gabriel et al.,
2008; Resa-Infante et al., 2008; Tarendeau et al., 2007, 2008),
respectively. Our list of 128 genes includes the importin subunit
b1 (KPNB1) and nuclear pore complex proteins Nup98 and
Cell Host & Microbe
ReviewNup153 (NUP98 and NUP153). Likely, these factors are involved
in the nuclear import of influenza virus RNPs, as well as in the
nuclear import of newly synthesized influenza viral proteins.
Genome Replication/Transcription and Translation
Once the vRNP complexes are imported into the nucleus, the
vRNA of influenza virus is transcribed into mRNA and replicated
via complementary RNA (cRNA) (reviewed in Engelhardt and
Fodor, 2006; Palese, 2007). The viral polymerase subunits
(PB1, PB2, and PA) and NP catalyze both genome replication
and transcription. Several host cellular molecules play a part in
these steps. Host factors shown to stimulate viral RNA synthesis
include BAT1 (or UAP56), heat shock protein (Hsp) 90, the mini-
chromosome maintenance (MCM) complex, Tat-SF1, and DNA-
dependent RNA polymerase II (Pol II) (Chan et al., 2006;
Engelhardt et al., 2005; Kawaguchi and Nagata, 2007; Momose
et al., 1996, 2001, 2002; Naito et al., 2007). BAT1, which is a
splicing factor for mRNA and also functions in the nuclear export
of cellular mRNA, interacts with NP to facilitate the formation of
the NP-RNA complex. Similarly, Tat-SF1 facilitates NP-vRNP
complex formation (Naito et al., 2007). Viral RNA synthesis is
then initiated by the viral RNA polymerase (Momose et al., 1996,
2001). Hsp90 stimulates viral RNA synthesis through its interac-
tion with PB2 (Momose et al., 1996, 2002). MCM, which functions
as a DNA replication fork helicase (Forsburg, 2004), plays a role in
influenza viral genome replication by promoting the association
between nascent cRNA and the viral polymerase complexes
during the transition from initiation to elongation, thus stabilizing
replication elongation complexes and allowing the synthesis of
full-length cRNA (Kawaguchi and Nagata, 2007). As described
above, the yeast library screen identified Tat-SF1 as a factor
involved in vRNA-NP complex formation and viral RNA synthesis
(Naito et al., 2007). In its active state, Pol II, which catalyzes the
synthesis of mRNA precursors and most snRNA and microRNAs,
is required for viral mRNA synthesis during the viral transcription
step (Chan et al., 2006; Engelhardt et al., 2005). Included in the
128 genes identified in our pair-wise comparison (Table S2) are
genes associated with pre-mRNA splicing (i.e., PTBP1,NHP2L1,
SNRP70, SF3B1, SF3A1, P14, and PRPF8), suggesting the
importance of the host mRNA splicing machinery for influenza
virus gene expression. Of interest, no splicing factors were found
in the screen carried out in Drosophila cells (Hao et al., 2008),
which is consistent with the finding that influenza virus mRNAs
were not spliced in this system (Hao et al., 2008).
Four screens identified NXF1 as an important host factor in
influenza virus replication (Table S3). NXF1 exports spliced
cellular mRNAs but rarely exports unspliced cellular mRNAs
(Reed and Cheng, 2005). Nonetheless, several viruses use the
NXF1 pathway for the nuclear export of unspliced viral RNAs
(Cullen, 2003). For influenza virus, NP interacts with BAT1/
UAP56 (Momose et al., 2001), which forms a bridge between
the NXF1/NXT1/Ref complex and the spliced mRNA. In addition,
NS1 binds NXF1 to suppress host mRNA export (Satterly et al.,
2007), perhaps to retain host mRNAs in the nucleus for ‘‘cap-
snatching.’’ In addition, the requirement of NXF1 for nuclear
export of viral mRNAs has recently been shown (Read and
Digard, 2010). Thus, influenza virus may exploit the NXF1-medi-
ated RNA export pathway for multiple purposes.
Influenza virus also uses the cellular machinery for mRNA
translation. Influenza virus infection shuts off host proteinsynthesis, thereby enhancing translation of viral mRNAs (Chen
and Krug, 2000; Chen et al., 1999; Fortes et al., 1994; Nemeroff
et al., 1998; Qiu and Krug, 1994). GRSF-1 (the cellular RNA
recognition motif containing the RNA-binding protein G-rich
sequence factor 1) and P58IPK (the cellular inhibitor of PKR, an
interferon-induced kinase that targets the eukaryotic translation
initiation factor eIF2) appear to be involved in the selective
synthesis of influenza viral proteins (Goodman et al., 2007;
Kash et al., 2002; Park et al., 1999). Analysis with Reactome
(Matthews et al., 2009) of the set of 128 genes that we identified
above revealed several host genes involved in the formation of
the translation initiation complex and the small ribosomal subunit
(i.e., FAU, EIF3S5, RPS3A, RPS4X, RPS10, RPS14, RPS5,
RPS16, EIF4A2, RPS20, and EIF3S8). It is possible that some
of these host factors promote virus-specific translation by
inhibiting host cellular mRNA translation and/or stimulating viral
mRNA translation.
vRNP Transport from the Nucleus to the Cytoplasm
Newly synthesized vRNPs are exported from the nucleus to the
cytoplasm (reviewed in Boulo et al., 2007). The viral matrix
protein, M1, and nuclear export protein, NEP/NS2, have critical
roles in this step. After M1 binds to the RNP complex, NEP/
NS2 attaches to the M1/RNP complex through its C-terminal
domain (Akarsu et al., 2003). NEP/NS2 can also bind to a host
cell nuclear export protein, CRM1 (Boulo et al., 2007; Elton
et al., 2001; Neumann et al., 2000). In addition, heat shock
cognate (Hsc) 70 protein and the MAP kinase cascade may
have roles in the nuclear export of vRNP complexes (Pleschka
et al., 2001; Watanabe et al., 2006).
Recently, phosphatidylinositol 3-kinase (PI3K) and its down-
stream effector protein (the kinase Akt) were identified as host
factors involved in influenza virus-induced signaling (Ehrhardt
and Ludwig, 2009; Ehrhardt et al., 2006; Hale et al., 2006; Shin
et al., 2007; Zhirnov and Klenk, 2007). Consistent with this
finding, three genes involved in the PI3K/AKT signaling pathway
(AKT1, MDM2, and IKBKE) were among the 128 genes identified
by the screens discussed here. Roles for this pathway in antiviral
activity and prevention of premature apoptosis have been
reported (Ehrhardt et al., 2006, 2007; Sarkar et al., 2004). Of
interest, a PI3K inhibitor obstructs the nuclear export of vRNPs,
as well as viral RNA and protein synthesis (Shin et al., 2007).
Assembly and Budding
In the late stage of the life cycle, the virion components, including
vRNPs, the matrix protein M1, and the viral envelope proteins
(HA, NA, and M2) are transported to the assembly site, the apical
plasma membrane in polarized epithelial cells (Nayak et al.,
2004). Relatively few host factors have been identified to be
involved in this stage. Of the six genome-wide screens dis-
cussed in this review, only two studies (Karlas et al., 2010;
Shapira et al., 2009) were designed to evaluate the assembly
and budding steps. Depletion of subunits of the COPI complex
reduced HA expression on the cell surface relative to the total
HA level in the screen by Brass et al. (2009) (Figure 4), suggesting
that the COPI complex plays a role in the transport of influenza
viral glycoproteins (i.e., HA and NA) to the cell surface, in addition
to its function in virus entry described above. The HA and NA
proteins contain signals for association with lipid rafts, which
are nonionic detergent-resistant lipid microdomains within the
plasma membrane. Influenza viruses preferentially bud fromCell Host & Microbe 7, June 17, 2010 ª2010 Elsevier Inc. 433
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Figure 4. Influenza Virus Life Cycle and Host Factors
Upon infection, influenza virus is internalized by receptor-mediated endocytosis. After membrane fusion between the virus envelope and the endosome, the viral
ribonucleoprotein (vRNP) complex is released into the cytoplasm and transported into the nucleus by the active import machinery of the host cell nuclear pore
complex. Replication and transcription of the viral genome take place in the nucleus, and many host factors are believed to be involved in this process. Newly
synthesized viral RNA associates with NP and forms the viral ribonucleoprotein (vRNP) complex together with viral polymerase proteins, which is then transported
from the nucleus to the cytoplasm. HA and NA are processed posttranslationally during their transport from the ER to the Golgi apparatus. During assembly and
budding, virion components are transported to the assembly site, the lipid raft microdomains at the apical plasma membrane of polarized epithelial cells. Progeny
viruses then bud from the cells. The light-orange rectangles indicate individual steps of the influenza virus life cycle. The light-blue rectangles indicate host cellular
processes that may be involved in the virus life cycle. Red circles indicate host factors identified in the screens discussed here, and yellow circles indicate host
factors identified in other previous studies.
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Lamb, 2005; Nayak et al., 2004; Takeda et al., 2003; Zhang
et al., 2000). Although the precise mechanism of M1-vRNP
complex transport to the cell surface is still unclear, the viral
M2 protein is thought to play a role in the incorporation of
M1-vRNPs into virus particles via an interaction between M1
and the M2 cytoplasmic tail (Iwatsuki-Horimoto et al., 2006;Figure 3. A Network of Host-Influenza Virus Interactions: Host and Vir
An interaction network between host and virions was analyzed and visualized in
virions and host proteins, respectively. Red circles indicate clusters associated w
MCODE analysis (Bader and Hogue, 2003): (1) translation initiation, (2) pre-mRNMcCown and Pekosz, 2005, 2006; Wu and Pekosz, 2008). NP
and M1 interact with host cytoskeletal components, such as
actin, presumably facilitating vRNP transport to the budding
site (Avalos et al., 1997). In the final step of the life cycle, the viral
membrane components are concentrated in the microdomains
of the lipid rafts, which may provide the stage for virus particle
release from the cell surface (Takeda et al., 2003). Althoughions
the same way described in Figure 1. Yellow and lilac nodes indicate influenza
ith particular biological processes in the interaction networks, as identified by
A processing, and (3) proton-transporting V-type ATPase.
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Reviewfew host factors have been found that participate in the budding
step, the actin cytoskeleton and Rab11, which belongs to the
Rab family of small GTPases, have been shown to contribute
to the budding of filamentous influenza virus particles (Bruce
et al., 2010; Roberts and Compans, 1998; Simpson-Holley
et al., 2002).Perspectives and Concluding Remarks
In 2003, the human genome project completed its mission of
identifying the 20,000–25,000 genes in human DNA. To deter-
mine host gene involvement in virus replication, genome-wide
screens, such as RNAi screens, offer an effective approach.
For influenza virus, among six independent genome-wide
screens, 1449 human genes, including 110 human orthologs
identified by a screen in Drosophila cells, have been identified
as host factors involved in influenza virus replication; of these,
128 genes were found in at least two screens. Bioinformatics
analysis of these 128 human genes revealed gene clusters
related to host cellular functions, such as endocytosis, transla-
tion initiation, and nuclear transport, all of which can be con-
nected to the influenza viral life cycle. Figure 4 illustrates
influenza virus-host interactions mapped to individual steps of
the influenza virus life cycle based on the known functions of
the identified host proteins. However, it should be borne in
mind that these proteins may be involved in other steps of the
viral life cycle with as yet undetermined functions.
Systematic, genome-wide RNAi screens are powerful tools for
identifying host genes important for viral replication. However,
they do have limitations; for example, the RNAi library does not
yet cover all of the human genes, the knockdown efficiency of
target gene expression could vary among siRNAs, and genes
whose siRNA knockdown leads to cytotoxicity would be elimi-
nated from a ‘‘hit list’’ even though they may be important for viral
replication, resulting in a number of false positives and false
negatives. Therefore, the identification of host gene candidates
involved in viral replication by any primary screen really repre-
sents no more than a starting point for exploration of such host
factors. More detailed functional analyses of human genes iden-
tified in genome-wide screens will allow us to find novel cellular
pathways and/or host gene sets important for influenza virus
replication, leading to a greater understanding of the precise
mechanisms of influenza virus replication.SUPPLEMENTAL INFORMATION
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